维普中文期刊产品整合服务
10篇 您的检索式:作者名="Alberto Breda"
    题名 作者 年代 出处 被引量
1Flexible Ureteroscopy and Laser Lithotripsy for Single Intrarenal Stones 2 cm or Greater—Is This the New Frontier?显示文摘Alberto Breda Oreoluwa Ogunyemi John T. Leppert John S. Lam Peter G. Schulam 2008The Journal of Urology2008,,3:3
2Flexible Ureteroscopy and Laser Lithotripsy for Multiple Unilateral Intrarenal Stones显示文摘Alberto Breda Oreoluwa Ogunyemi John T. Leppert Peter G. Schulam 2008European Urology2008,,5:2
3Flexible Ureteroscopy and Laser Lithotripsy for Multiple Unilateral Intrarenal Stones显示文摘Alberto Breda Oreoluwa Ogunyemi John T. Leppert Peter G. Schulam 2008European Urology2008,,5:2
4Flexible Ureteroscopy and Laser Lithotripsy for Multiple Unilateral Intrarenal Stones显示文摘Alberto Breda Oreoluwa Ogunyemi John T. Leppert Peter G. Schulam 2008European Urology2008,,5:1
5Complications of Laparoscopic Surgery for Renal Masses: Prevention, Management, and Comparison with the Open Experience显示文摘Alberto Breda Antonio Finelli Gunter Janetschek Francesco Porpiglia Francesco Montorsi 2009European Urology2009,,:1
6Flexible Ureteroscopy and Laser Lithotripsy for Single Intrarenal Stones 2 cm or Greater—Is This the New Frontier?显示文摘Alberto Breda Oreoluwa Ogunyemi John T. Leppert John S. Lam Peter G. Schulam 2008The Journal of Urology2008,,3:1
7Laparoscopic renal surgery for benign disease显示文摘Joseph C. Liao MD Alberto Breda MD Peter G. Schulam MD PhD 2007Current Urology Reports2007,,1:1
8Upper urinary tract urothelial cell carcinoma: location as a predictive factor for concomitant bladder carcinoma显示文摘Marco Cosentino Joan Palou Josep M. Gaya Alberto Breda Oscar Rodriguez-Faba Humberto Villavicencio-Mavrich 2013World Journal of Urology2013,,:1
9Robot-assisted oncologic pelvic surgery with Hugo™robot-assisted surgery system:A single-center experience显示文摘Objective To report the outcomes of intra-and extra-peritoneal robot-assisted radical prostatectomy(RARP)and robot-assisted radical cystectomy(RARC)with Hugo™robot-assisted surgery(RAS)system(Medtronic,Minneapolis,MN,USA).Methods Data of twenty patients who underwent RARP and one RARC at our institution between February 2022 and January 2023 were reported.The primary endpoint of the study was to report the surgical setting of Hugo™RAS system to perform RARP and RARC.The secondary endpoint was to assess the feasibility of RARP and RARC with this novel robotic platform and report the outcomes.Results Seventeen patients underwent RARP with a transperitoneal approach,and three with an extraperitoneal approach;and one patient underwent RARC with intracorporeal ileal conduit.No intraoperative complications occurred.Median docking and console time were 12(interquartile range[IQR]7-16)min and 185(IQR 177-192)min for transperitoneal RARP,15(IQR 12-17)min and 170(IQR 162-185)min for extraperitoneal RARP.No intraoperative complications occurred.One patient submitted to extraperitoneal RARP had a urinary tract infection in the postoperative period that required an antibiotic treatment(Clavien-Dindo Grade 2).In case of transperitoneal RARP,two minor complications occurred(one pelvic hematoma and one urinary tract infection;both Clavien-Dindo Grade 2).Conclusion Hugo™RAS system is a novel promising robotic platform that allows to perform major oncological pelvic surgery.We showed the feasibility of RARP both intra-and extra-peritoneally and RARC with intracorporeal ileal conduit with this novel platform.Angelo Territo Alessandro Uleri Andrea Gallioli Josep Maria Gaya Paolo Verri Giuseppe Basile Alba Farré Alejandra Bravo Alessandro Tedde Óscar Rodríguez Faba Joan Palou Alberto Breda 2023Asian Journal of Urology2023,10,4:0
10Small renal masses in kidney transplantation:Overview of clinical impact and management in donors and recipients显示文摘Kidney transplantation is the best replacement treatment for the end-stage renal disease.Currently,the imbalance between the number of patients on a transplant list and the number of organs available constitutes the crucial limitation of this approach.To expand the pool of organs amenable for transplantation,kidneys coming from older patients have been employed;however,the combination of these organs in conjunction with the chronic use of immunosuppressive therapy increases the risk of incidence of graft small renal tumors.This narrative review aims to provide the state of the art on the clinical impact and management of incidentally diagnosed small renal tumors in either donors or recipients.According to the most updated evidence,the use of grafts with a small renal mass,after bench table tumor excision,may be considered a safe option for high-risk patients in hemodialysis.On the other hand,an early small renal mass finding on periodic ultrasound-evaluation in the graft should allow to perform a conservative treatment in order to preserve renal function.Finally,in case of a renal tumor in native kidney,a radical nephrectomy is usually recommended.Alberto Piana Iulia Andras Pietro Diana Paolo Verri Andrea Gallioli Riccardo Campi Thomas Prudhomme Vital Hevia Romain Boissier Alberto Breda Angelo Territo 2022Asian Journal of Urology2022,9,3:0
返回顶部 每页显示:
共1页 首页 上一页 第1页 下一页 末页 /1 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费